Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.


BACKGROUND Rilpivirine-based regimens are now preferred or alternative first-line regimens according to many HIV treatment guidelines. Recently, a surveillance study conducted in Argentina determined that prevalence of pretreatment resistance to first-generation non-nucleoside reverse transcriptase inhibitors (NNRTIs) was 10%. The aim of this study was to… (More)
DOI: 10.3851/IMP3147

2 Figures and Tables


  • Presentations referencing similar topics